Nisa Investment Advisors’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.14K | Sell |
2,635
-1,735
| -40% | -$5.36K | ﹤0.01% | 2346 |
|
|
2025
Q1 | $15.3K | Buy |
4,370
+203
| +5% | +$708 | ﹤0.01% | 1991 |
|
|
2024
Q4 | $13.6K | Sell |
4,167
-250
| -6% | -$817 | ﹤0.01% | 2052 |
|
|
2024
Q3 | $17K | Buy |
4,417
+250
| +6% | +$962 | ﹤0.01% | 1960 |
|
|
2024
Q2 | $12.9K | Buy |
4,167
+342
| +9% | +$1.06K | ﹤0.01% | 2073 |
|
|
2024
Q1 | $9.87K | Hold |
3,825
| – | – | ﹤0.01% | 2035 |
|
|
2023
Q4 | $9.56K | Buy |
3,825
+75
| +2% | +$188 | ﹤0.01% | 2052 |
|
|
2023
Q3 | $7.61K | Sell |
3,750
-52
| -1% | -$106 | ﹤0.01% | 2227 |
|
|
2023
Q2 | $8.75K | Hold |
3,802
| – | – | ﹤0.01% | 2279 |
|
|
2023
Q1 | $12K | Hold |
3,802
| – | – | ﹤0.01% | 2126 |
|
|
2022
Q4 | $9K | Buy |
3,802
+52
| +1% | +$123 | ﹤0.01% | 2217 |
|
|
2022
Q3 | $9K | Sell |
3,750
-2,400
| -39% | -$5.76K | ﹤0.01% | 2199 |
|
|
2022
Q2 | $17K | Buy |
6,150
+3,450
| +128% | +$9.54K | ﹤0.01% | 2081 |
|
|
2022
Q1 | $8K | Buy |
+2,700
| New | +$8K | ﹤0.01% | 2236 |
|